| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 903 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 903 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 113 | -4.343 | 831 | 2.737 | 106 | 104 | 101 | 102 | 101 | 101 |
| Gross Profit/Loss - EUR | -113 | 4.343 | -831 | -1.834 | -106 | -104 | -101 | -102 | -101 | -101 |
| Net Profit/Loss - EUR | -113 | 4.343 | -831 | -1.861 | -106 | -104 | -101 | -102 | -101 | -101 |
| Employees | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Prolife Probiotics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.214 | 1.090 | 962 | 819 | 697 | 580 | 466 | 365 | 263 | 160 |
| Current Assets | 0 | 0 | 18 | 941 | 923 | 906 | 47 | 47 | 47 | 46 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 18 | 48 | 47 | 46 | 45 | 45 | 45 | 45 |
| Cash | 0 | 0 | 0 | 894 | 876 | 860 | 2 | 2 | 2 | 2 |
| Shareholders Funds | -34.661 | -29.964 | -26.018 | -31.594 | -31.088 | -30.602 | -30.025 | -30.220 | -30.230 | -30.162 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 35.874 | 31.054 | 26.998 | 33.354 | 32.708 | 32.088 | 30.537 | 30.632 | 30.539 | 30.368 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Prolife Probiotics S.r.l.